| Dr Christopher Wilhelmson, MD | |
|
363 Fremont St Ste 308a, Battle Creek, MI 49017-3391 | |
| (269) 245-8310 | |
| (269) 245-8345 |
| Full Name | Dr Christopher Wilhelmson |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 29 Years |
| Location | 363 Fremont St Ste 308a, Battle Creek, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083608434 | NPI | - | NPPES |
| 020A310890 | Other | MI | BCBS GROUP |
| 1730017 | Other | MI | PHYSICIAN HEALTH PLAN PIN |
| 383689447056 | Other | MI | COMMUNITY CHOICE MICHIGAN |
| 0131080 | Other | MI | BLUECARE NETWORK |
| 0201310802 | Other | MI | BCBS INDIVIDUAL PIN |
| 4589737 | Medicaid | MI | |
| 7854563 | Other | MI | AETNA PIN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bronson Battle Creek Hospital | Battle creek, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bronson Battle Creek Hospital | 0547173478 | 157 |
News Archive
The Washington Post reports on Duke University's experiment with community health centers Duke University has been focusing closer attention on the neighborhood that surrounds it by forming a partnership with Durham's Federally Qualified Health Center.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports.
› Verified 9 days ago
| Entity Name | Bronson Battle Creek Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093119638 PECOS PAC ID: 0547173478 Enrollment ID: O20041103000774 |
News Archive
The Washington Post reports on Duke University's experiment with community health centers Duke University has been focusing closer attention on the neighborhood that surrounds it by forming a partnership with Durham's Federally Qualified Health Center.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Wilhelmson, MD 363 Fremont St, Suite 208, Battle Creek, MI 49017-3389 Ph: (269) 245-8310 | Dr Christopher Wilhelmson, MD 363 Fremont St Ste 308a, Battle Creek, MI 49017-3391 Ph: (269) 245-8310 |
News Archive
The Washington Post reports on Duke University's experiment with community health centers Duke University has been focusing closer attention on the neighborhood that surrounds it by forming a partnership with Durham's Federally Qualified Health Center.
Nordion Inc., a leading provider of products and services to the global health science market, today reported results for the fiscal third quarter ended July 31, 2012. The Company generated $67.1 million in revenue for the third quarter, an increase of $0.3 million, or 0.5%, over revenue of $66.8 million for the same period in 2011.
A team of scientists led by the University of Southampton has taken an important step forward in research efforts that could one day lead to an effective vaccine against the world's deadliest infectious disease.
Laboratory Corporation of America Holdings, today announced that it has entered into a definitive agreement under which LabCorp will acquire Genzyme Genetics, a business unit of Genzyme Corp., in an all cash transaction valued at $925 million. Net of expected income tax benefits, less acquisition related expenses, the acquisition has a net cash cost to LabCorp of approximately $795 million.
Sanofi Pasteur, the vaccines division of the pharmaceutical group Sanofi-Aventis, on Thursday announced the company had begun testing its dengue fever vaccine in a Phase III clinical trial in Australia, Dow Jones/Wall Street Journal reports.
› Verified 9 days ago
Abedel Karim Abushmaies, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2845 Capital Ave Sw, Ste 201, Battle Creek, MI 49015 Phone: 269-979-6310 Fax: 269-979-6311 | |
Dr. David Michael Bartholomew, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St, Suite 208, Battle Creek, MI 49017 Phone: 269-245-8310 Fax: 269-245-8345 | |
Mohammad A Rahman, MD Surgery Medicare: Medicare Enrolled Practice Location: 2845 Capital Ave Sw, Ste 201, Battle Creek, MI 49015 Phone: 269-979-6310 Fax: 269-979-6311 | |
Syed M.f. Alam, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 3790 Capital Ave Sw, Battle Creek, MI 49015 Phone: 269-979-6310 Fax: 269-979-8807 | |
Jeffrey R Mitchell, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont Street, Suite 203, Battle Creek, MI 49017 Phone: 269-969-6123 Fax: 269-969-6122 | |
Dr. Kerri Murray, M.D., FACS Surgery Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St, Suite 300, Battle Creek, MI 49017 Phone: 269-966-8350 |